Replies to post #18603 on Oncolix Inc. (fka ONCX)

[reaper247]

LOL, namtae…what?

Maybe the toxic noteholders, toxic warrant holders & toxic preferred holders will just let Oncolix off the hook, in the spirit of the upcoming holiday season

Did people miss the fact that Oncolix note holders agreed to accrued interest and equity repayment until April 2019?

The only optimism, as it relates to Oncolix, is the fact they havent filed for BK protection yet, as far as we know

First off, ONCX secured additional financing with that equity and interest accrued until 2019 as well.

There is no need to file for a BK and if they had, it would be a material event requiring an 8-K.

The same would be true if Prolanta failed in FDA clinical trials.

People make outrageous claims against the company, when verifiable facts can easily be provided to show them to be wrong.

LOL, IMO and FWIW.